Pau Abrisqueta-Costa
10PUBLICATIONS
79CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Mar 31, 2026
Lenalidomide plus rituximab for previously untreated advanced follicular lymphoma: the 10-year RELEVANCE trial analysis.Nicolas Gower, Pierre Feugier, Jason R Westin
|Sep 24, 2025
Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma.Franck Morschhauser, Gilles Salles, Laurie H Sehn
|Sep 08, 2025
Fixed-duration epcoritamab plus R2 drives favorable outcomes in relapsed or refractory follicular lymphoma.Lorenzo Falchi, Anna Sureda, Sirpa Leppä
|Jul 16, 2025
Tafasitamab plus lenalidomide as salvage therapy in diffuse large B-cell lymphoma: real-world experience from GELTAMO.Antonio Gutierrez, Izaskun Zeberio, Francisco Javier Peñalver
|Dec 17, 2024
Real-World Evidence on Adverse Events and Healthcare Resource Utilization in Patients with Chronic Lymphocytic Leukaemia in Spain Using Natural Language Processing: The SRealCLL Study.Pau Abrisqueta-Costa, José Antonio García-Marco, Antonio Gutiérrez
|Apr 10, 2024
Safety and efficacy of parsaclisib in combination with rituximab, bendamustine + rituximab, or ibrutinib in patients with previously treated B-cell lymphoma: analysis of a phase 1 dose-finding study (CITADEL‑112).Juan-Manuel Sancho, Pau Abrisqueta, Abhijeet Kumar
Pageof 2
Frequent Collaborators
2 joint publications
Antonio Gutierrez
2 joint publications
Gilles Salles
2 joint publications
Franck Morschhauser
1 joint publications
Miguel Alcoceba
1 joint publications
Juan-Manuel Sancho
1 joint publications
Raul Cordoba
1 joint publications
Teng Liu
1 joint publications
Armando Lopez-Guillermo
1 joint publications
Javier Loscertales
1 joint publications
Francisco Javier Penalvar
